Repairon Immuno

Repairon Immuno is dedicated to pioneering advancements in biotechnology research, focusing on the development of innovative cell therapies. Repairon Immuno is committed to addressing some of the most challenging diseases through cutting-edge research and development.

With a focus on induced Pluripotent Stem Cell (iPSC) technology, Repairon Immuno is leveraging exclusively licensed iPSC lines, including one currently undergoing validation in a European clinical trial. This commitment to innovation allows Repairon Immuno to generate novel cell drug products through a proprietary, scalable, GMP-compliant differentiation platform, and proprietary gene editing designs.

Repairon Immuno's dedication to biotechnology research positions it as a key player in the field, driving progress and offering new hope for patients. The information will be completed soon with the support of the company’s management. We invite the management of Repairon Immuno to create a customized and exclusive company showcase and product listing on our platform.